It promotes HCC cell migration and invasion by altering the m6A modification of inhibitor of DNA binding 2 (ID2) and GATA binding protein 3 (GATA3) mRNA (79, 80). The gene discussed is GATA3; the disease is hepatocellular carcinoma.